Ignite Creation Date:
2024-05-06 @ 7:05 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05880706
Status:
RECRUITING
Last Update Posted:
2023-08-31
First Post:
2023-05-17
Brief Title:
A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Sponsor:
Sichuan Baili Pharmaceutical Co Ltd
Organization:
Sichuan Baili Pharmaceutical Co Ltd
Organization Data
Organization:
Sichuan Baili Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
BL-B01D1-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sichuan Baili Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None